CellSource Co., Ltd.
4880.T · JPX
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -9.83 | -1.31 | -3.51 | 1.46 |
| FCF Yield | 2.90% | 0.22% | 1.45% | 0.91% |
| EV / EBITDA | 16.96 | 42.85 | 22.19 | 47.97 |
| Quality | ||||
| ROIC | 0.25% | 1.57% | 14.11% | 26.67% |
| Gross Margin | 56.24% | 55.51% | 70.60% | 71.70% |
| Cash Conversion Ratio | 31.25 | 2.01 | 0.68 | 0.54 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.29% | 0.63% | 15.57% | 32.06% |
| Free Cash Flow Growth | 457.12% | -89.33% | -34.84% | -10.55% |
| Safety | ||||
| Net Debt / EBITDA | -14.76 | -9.44 | -3.58 | -1.90 |
| Interest Coverage | 126.87 | 94.83 | 3,222.95 | 142,822.91 |
| Efficiency | ||||
| Inventory Turnover | 6.10 | 6.83 | 4.33 | 5.33 |
| Cash Conversion Cycle | 78.63 | 63.49 | 92.69 | 90.90 |